Metis MedTech

Investorcompany

Member since November 2026

—

Volume

—

Sold

—

Financed

—

Closed

—

Area

AI SummaryBeta

Metis MedTech is an investor company that became a member in November 2026. Recently, it participated in the $30 million oversubscribed Series A round for StimCardio Medical to advance treatment for atrial fibrillation.

AI-generated from Traded deal data. May contain errors.

About

Metis MedTech is an investment and strategic advisory platform focused on supporting medical device companies through financing and commercialization. Founded by John Slump, the firm aims to provide aligned capital and operator-level partnerships to help founders navigate critical growth stages in the medical technology sector.

Markets

Headquarters

Chicago, Illinois, United States

On the web

Member since: November 2026

Deals

RAISE

StimCardio Medical Closes $30 Million Oversubscribed Series A To Advance Atrial Fibrillation Treatment

CRE

Oct 23, 2026